Evidence map›Paper›PMID 31983530›Full record

ArticleEuropean neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology2020

The adverse effects of pramipexole on probability discounting are not reversed by acute D

Marco Orrù, Hunter J Strathman, Gabriele Floris, Simona Scheggi, Beth Levant, Marco Bortolato

Open access · greenAbstract read
In one paragraph

Article in European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Marco OrrùDepartment of Pharmacology and Toxicology, College of Pharmacy, University of Utah, Skaggs Hall, Room 3916, 30 S 2000 E, Salt Lake City, UT, Unites States.
Hunter J StrathmanDepartment of Pharmacology and Toxicology, College of Pharmacy, University of Utah, Skaggs Hall, Room 3916, 30 S 2000 E, Salt Lake City, UT, Unites States.
Gabriele FlorisDepartment of Pharmacology and Toxicology, College of Pharmacy, University of Utah, Skaggs Hall, Room 3916, 30 S 2000 E, Salt Lake City, UT, Unites States.
Simona ScheggiDepartment of Pharmacology and Toxicology, College of Pharmacy, University of Utah, Skaggs Hall, Room 3916, 30 S 2000 E, Salt Lake City, UT, Unites States; Department of Molecular and Developmental Medicine, School of Medicine, University of Siena, Italy.
Beth LevantDepartment of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, KS, Unites States.
Marco BortolatoDepartment of Pharmacology and Toxicology, College of Pharmacy, University of Utah, Skaggs Hall, Room 3916, 30 S 2000 E, Salt Lake City, UT, Unites States. Electronic address: marco.bortolato@utah.edu.
University of Utah · USUniversity of Kansas Medical Center · US

Funding

Exploring the role of neurosteroids in tic modulationR21NS108722 · NINDS · UNIVERSITY OF UTAH · PI BORTOLATO, MARCO, PITTENGER, CHRISTOPHER JOHN · 2018 to 2019
$428k
NINDS NIH HHS R21 NS108722
6 · The paper itself

Abstract

Pramipexole (PPX) is a D

Indexed as

AnimalsDelay DiscountingDiscrimination LearningDopamine AgonistsDopamine D2 Receptor AntagonistsMalePramipexoleRatsRats, Long-EvansReaction TimeReceptors, Dopamine D2Receptors, Dopamine D3Dopamine AgonistsDopamine D2 Receptor AntagonistsPramipexoleReceptors, Dopamine D2Receptors, Dopamine D3D(3) dopamine receptorsNovelty seekingNucleus accumbensPramipexoleProbability discountingRisk taking

Identifiers

PMID31983530
PMCPMC9325630
OpenAlexW3001520256

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.